Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Temozolomide and oral VP-16 for children and young adults with recurrent or treatment-induced malignant gliomas.

Korones DN, Smith A, Foreman N, Bouffet E.

Pediatr Blood Cancer. 2006 Jul;47(1):37-41.

PMID:
16047359
2.

The use of temozolomide in recurrent malignant gliomas.

Gaya A, Rees J, Greenstein A, Stebbing J.

Cancer Treat Rev. 2002 Apr;28(2):115-20. Review.

PMID:
12297119
3.

Treatment of infants with malignant gliomas: the Pediatric Oncology Group experience.

Duffner PK, Krischer JP, Burger PC, Cohen ME, Backstrom JW, Horowitz ME, Sanford RA, Friedman HS, Kun LE.

J Neurooncol. 1996 May-Jun;28(2-3):245-56. Review.

PMID:
8832466
4.

Radiotherapy for brainstem gliomas in children and adults: A single-institution experience and literature review.

Yoshida K, Sulaiman NS, Miyawaki D, Ejima Y, Nishimura H, Ishihara T, Matsuo Y, Nishikawa R, Sasayama T, Hayakawa A, Kohmura E, Sasaki R.

Asia Pac J Clin Oncol. 2017 Apr;13(2):e153-e160. doi: 10.1111/ajco.12451. Epub 2016 Mar 3. Review.

PMID:
26935004
5.

The expanding role of chemotherapy for pediatric supratentorial malignant gliomas.

Lyden DC, Mason WP, Finlay JL.

J Neurooncol. 1996 May-Jun;28(2-3):185-91. Review.

PMID:
8832461
6.

Interstitial chemotherapy for malignant gliomas: the Johns Hopkins experience.

Lawson HC, Sampath P, Bohan E, Park MC, Hussain N, Olivi A, Weingart J, Kleinberg L, Brem H.

J Neurooncol. 2007 May;83(1):61-70. Epub 2006 Dec 14. Review.

7.

Malignant gliomas: old and new systemic treatment approaches.

Mesti T, Ocvirk J.

Radiol Oncol. 2016 Apr 23;50(2):129-38. doi: 10.1515/raon-2015-0003. eCollection 2016 Jun 1. Review.

Supplemental Content

Support Center